Concepedia

Bairong Xia

BX

Statistics

Publications

6

Citations

234

H-Index

6

Active since

2002

Affiliations

Zhongnan Hospital of Wuhan University(Current)

Wuhan University

First Affiliated Hospital of Nanchang University

Hunan Cancer Hospital

First Affiliated Hospital of Soochow University

Bairong Xia is an author at Zhongnan Hospital of Wuhan University specializing in life sciences, genetics, and inflammatory bowel disease genetics.

ORCID

Publications per year

2002–2024

6

Publications

6

Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China

Xiaohua Wu, Yang Sun, Hongying Yang et al. · The Lancet · 2024 · 102 citations

, , +13

CTLA4 Gene Polymorphisms in Dutch and Chinese Patients with Inflammatory Bowel Disease

Bairong Xia, J. Bart A. Crusius, Antonie Zwiers et al. · Scandinavian Journal of Gastroenterology · 2002 · 48 citations

, , +16

Polymorphisms of CD14 gene and TLR4 gene are not associated with ulcerative colitis in Chinese patients

Qianren Guo, Bairong Xia, Yi Jiang et al. · Postgraduate Medical Journal · 2005 · 37 citations · Full text

, , +17

LBA93 EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC)

Ying Cheng, Ying Liu, W. Zhang et al. · Annals of Oncology · 2023 · 26 citations · Full text

, , +10

Polymorphism of HLA‐DRB1 gene shows no strong association with ulcerative colitis in Chinese patients

Ming Lü, Bairong Xia · International Journal of Immunogenetics · 2005 · 11 citations · Full text

, , +17

1–5 of 6